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1056-l 20 Platelet-Activating Factor-Like Lipids Mediate 
Endothelial Cell Apoptosis Induced by 
Hypercholesterolemic Low-Density Lipoprotein 
Jonathan Lu, Gopal K. Mar&be, Chao-Yuh Yang, Wei Jiang, Jun.Hai Yang, Henry J. 
Pownall, Philip D. Henry, Chu-Huana Chen. Baylor College of Medicine, Houston, TX, 
University of Utah, Salt Lake City, UT 
Background: Atherosclerosis is an inflammatory disease and platelet-activating factor 
(PAF)-like lipids are potent proinflammatory factors. However, their role in the apoptosis 
of vascular endothelial cells (EC), an important step in atherosclerosis, has not been 
identified. We recently demonstrated that L5, the most electronegative and a mildly oxi- 
dlzed subfraction of LDL isolated from hypercholesterolemic human plasma, mduces 
apoptosls in cultured EC. Methods: We tested the mediator role of PAF-like lipids I” L5- 
induced apoptosls. As a reference, the effects of L5 were compared with those of well- 
characterized copper-oxidized LDL (oxLDL). Results: In bovine aortic EC cultures, both 
L5 (50 pg/mL) and oxLDL (50 p&j/mL) inhibited fibroblast growth factor 2 (FGFP) tran- 
scription and Akt phosphorylation. Concomitantly monitored 6~1.2 family proteins 
revealed reducbon in Bcl-P/Bax ratios, partly explaining ensuing apoptosis. FGFP over- 
expression presewed Akt phosphorylation and prevented the B&O-dependent apopto- 
sis. WEB-2066 IS an antagonist for the Gicoupled PAF receptor (PAFR) or PAFR-llke 
receptors. WEB-2086 (IO PM) or Gideactivator pertussis toxin (100 ng/mL) effectively 
attenuated FGF2 downregulation and the associated apoptosis in cells exposed to either 
L5 or oxLDL. Phosphollpids isolated from oxLDL also induced apoptosis by downregulat- 
ing FGFP. Pretreating L5 and oxLDL-derived phospholipids with a recombinant PAF 
acetylhydrolase, a phospholipase A2 that specifically hydrolyzes the short-chain acetyl 
group at the sr?P site of PAF-like phospholipids. abolished their effects. In contrast, pre- 
treatmg L5 and oxLDL-derived phospholipids with phospholipase AI had no influence on 
their effects. Conclusion: Our findings indicate that PAF-like lipids mediate the apoptotic 
signal of L5 circulating in patients with hypercholesterolemia. OxLDL mimics L5 function- 
ally because its signal is mediated by similar mediators. 
1056-121 The Modification of Epitopes on Low Density 
Lipoprotein by Homocysteine May Affect the Affinity of 
LDL to LDL Receptors 
Yonq-Xln Sun, Fu Wai Cardiovascular Dtsease Hospital, Beijing, People’s Republic of 
China, Fudan University. Shanghai, People’s Republic of China 
Background: ApoB-100 IS the only lipoprotein component in low density lipoprotein 
(LDL). The intravascular metabolism of apoB-100 remams unclear. The increase of LDL 
in plasma and hyperhomocysteinemia are the important cardiovascular risk factors. A 
tiny amount of homocysteine in serum automatically circularizes and changes into a 
chemical group liking to the free radical, homocysteine thiolectone (HCTL). Objectives: 
Our project focuses on the change of the immunoreactivity of different epitopes on 
homocysteina modified LDL which could be recognized by LDL monoclonal antibodies 
(mcAb) in vitro. Methods We obtained plasma LDL from heathy volunteers and sepa- 
rate the extracted LDL into two parts (LDL modified by HCTL and unmodified LDL). Eigh- 
teen fine mapped monoclonal antibodies are employed to detect the altered 
immunoreactlvlty of homocysteine modified LDL by RIA assay. Results: We found that 
the immunoreactivity of 3 amino acid epitopes on homocysteine modified LDL (2D8: 
1438-1481,3F5: 2835-2922 and 4G3: 2960-3084 amino acid sequences respectively) 
were conspicuously declined as recognized by respective moncclonal antibodies. Inter- 
estrngly, the epitopes of 3F5 and 4G3 are situated near or within the LDL receptor bind- 
ing domarn of apoB-100. Conclusion: The declinations within 3F5 and 4G3 epltopes 
might have physiological and pathological significance I” that the declinations alter the 
affinity of modified LDL to LDL-receptors, therefore, increase the affinity to scavenger 
receptors and Initiate the atherosclerosis process. 
1056-l 22 Mediterranean and Low Fat Diets Are Associated With 
Similar Lipid Levels at 12 Months in Patients With 
Coronary Heart Disease on Statin Therapy 
David M. Colauhoun, Paul Glasziou. Shawn Somerset, Sandi Pirouo, Pam Horsley, 
Kathleen Irish. Jeannet Weyers. Core Research Group, Brisbane, Australia. The 
Urwersity of Queensland. Brisbane, Australra 
Background: A low fat diet is recommended for patients with coronary heart disease 
(CHD). A high fat mediterranean diet, rich in mownsaturates (MUFA) is associated with 
low CHD rates and is as effective as Low Fat in lowering cholesterol. Long-term relative 
efficacy of diets for patients on statins is unknown. This study compared Low Fat to Med- 
iterranean diets on lipids and lipoproteins in patients with CHD on standard therapy 
(including statins). 
Method:68 patlents with angiographic CHD were randomised to Low Fat (fat 20-25 % of 
Energy, saturated fat 8- IO % energy) or Mediterranean (fat 35.40 % energy. > 50% of fat 
as MUFA). Lipids were measured prior to drug therapy, at randomisation and at 3 and I2 
months. 
Results: At randomisation and 12 months, 86 % Low Fat patients and 80 % Mediterra- 
nean patients were on statins. Similarly, 80% Low Fat and 85 % Meditarrenean pabents 
were taking aspinn. Mean fat intake in Low Fat dret was 20% of total energy (SFA 8.5 % 
of total energy) compared to Mediterranean diet with fat 34% of total energy (57 % of fat 
as MUFA). 
Conclusions: Mediterranean and Low Fat diets are associated wth similar lipid and lipo- 
protein levels at one year in patients with CHD on standard therapy. Recommendations 
for CHD patients ought to condsider a Mediterranean diet as an alternatw? to Low Fat. 







Low Fat Mediterranean 
n=34 n = 35 
Week 3 I2 Week 3 I2 
0 Month Month 0 Month Month 
4.48 4.44 4.42 4.43 4.34 4.52 
1.59 1.63 1.56 1.48 I.38 1.48 
1.11 1.17 1.21 117 I.2 1.24 
LDL- 3.92 2.61 2.51 2.52 2.58 2.46 2.62 
Cholesterol 
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1057-l 46 Theaflavin-Enriched Green Tea Extract Lowers Low- 
Density Lipoprotein Cholesterol 
David J. Maron, Guo Ping Lu, Cai Nai Sheng, Zhong Gui Wu, Yue Hua Li, Hui Chen, Jian 
Qiu Zhu, Xue Juan Jln, Bert C. Wouters, Jim Zhao, Vanderbilt University Medical Center, 
Nashville, TN 
Backgrounct Epidemiologic studies suggest that drinking multrple cops of tea per day 
lowers low-densrty lipoprotein cholesterol (LDL), but previous trials of tea drinking and 
admimstration of green tea extract have falled to show any impact on lipids and lipopro- 
teins in humans. Theaflavins are formed when green tea is fermented to produce black 
tea, and animal studies show that green tea catechins and black tea polyphenols 
increase fecal excretion of fat and cholesterol. Hypothesis: A green tea extract enriched 
with theaflavins wll have a favorable effect on the lipid profile of subjects with mild to 
moderate hypercholesterolemia. Methods A double-blind, randomized, placebo-con- 
trolled, parallel-group trial involving 240 men and women age I8 years or older on a low 
fat diet with baseline LDL between 130-190 mg/dL in 6 outpatrent clinics in China. Sub- 
jects were given a daily capsule contaming theaflavin-enriched green tea extract (375 
mg) or placebo for I2 weeks. Results: Mean levels (&EM) of total cholesterol, LDL, 
high density lipoprotein cholesterol (HDL), and triglycerides changed by -1 I .3 * 0.9% 
(P=O.Ol), -16.4r 1.1% (P=O.O1), +2.3*2.1% (P=NS), and+2.6+3.5% (P=NS) respec- 
twely in the tea extract group. Mean levels of total cholesterol, LDL, HDL, and triglycer- 
ides did not change significantly in the placebo group. No significant adverse events 
were observed. Conclusions: Theaflavin-enriched green tea extract is an effective 
adlunct to a low fat diet to lower LDL in hypercholesterolemic adults and is well tolerated. 
1057-147 Effects of a Carbohydrate-Restricted Diet Versus a Fat- 
and Calorie-Restricted Diet on Lipid Subfractions 
Frederick F. Samaha Prakash Seshadri, Nayyar Iqbal, Linda Stern, Philadephia VA 
Medlcal Center, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA 
Introduction: Low carbohydrate (Low Carb) diets have recently galned popularity. While 
preliminary data suggest no adverse effect of a Low Carb diet on standard serum llpid 
levels, there is concern that such diets may adversely shift lkpid subfractions to a more 
atherogenic profile relative to a fat- and calorie-restricted (Low Fat) diet. We randomized 
80 subjects with severs obesity and a high prevalence (79%) of diabetes or metabolic 
syndrome to a Low Carb versus a Low Fat diet, and assessed the effects on lipid sub- 
fractions known to increase risk of coronary artery disease (CAD)(small dense low den- 
slty lipoprotein (LDL) cholesterol particles and large very low density lkpoprotein (VLDL) 
particles), as well as effects on large high density lipoprotein (HDL) cholesterol pafticles 
which have been shown to be protective against CAD. 
Methods: After randomization, subjects received intensive instruction on a Low Carb ver- 
sus a Low Fat diet. Lipid particle sizes were measured using nuclear magnetic reso- 
nance SpeCtroscopy at 6 months, from which concentrations (expressed in medians 
(interquartile range)) of lipid subfractions were derived. 
Results: Low Carb group subjects experienced a greater decrease in large VLDL (from 
46 (15,79) mg/dl to I5 (4,33) mg/dl) versus the Low Fat group (from 51 (17,96) mg/dl to 
21 (13.69) mgldl (p=O 031). The Low Carb group demonstrated a trend toward a greater 
decrease in small dense LDL particle concentration (from 0 (0,53) mg/dl to 0 (0,8) mgldl) 
versus the Low Fat group (from IO (0,83) mg/dl to 0 (0, 60) mg/dl)(p=0.13). Subjects in 
the Low Carb group also demonstrated a trend toward a greater increase in the concen- 
tration of large HDL parilcles in the Low Carb group (increasing from 12 (7,18) mgidl to 
I4 (11,22) mg/dl) versus the Low Fat group (from IO (7,16) mg/dl to 12 (8.18) mgidl) 
(p=O.O6). 
Conclusions: Subjects with severs obesity and a high prevalence of diabetes or meta- 
bolic syndrome demonstrate a shift to a more favorable lipid subfraction profile after 6 
months on a carbohydrate-restricted diet compared to a calorie- and fat-restrlcted diet. 
